Dalan's unique insect vaccine technology will be the only prophylactic solution protecting the world's honeybees from infectious deadly diseases such as American Foulbrood.
Dalan has received the go-ahead from the U.S. Department of Agriculture to pursue a conditional approval process for the first ever honey bee vaccine.
The Dalan vaccine technology exposes queen bees to inactive — i.e. “dead” — American foulbrood bacteria, and other dead pathogens, which enables the larvae hatched in the hive to resist American Foulbrood infection
The Dalan vaccine technology exposes queen bees to inactive — i.e. “dead” — American foulbrood bacteria, and other dead pathogens, which enables the larvae hatched in the hive to resist American Foulbrood infection
Globally, pollination contributes $300B+ every year to a variety of markets. Commercially operated beehives is an $10B+ market. Sick and dying hives put global markets at risk. Currently, there are no safe and effective prophylactic solutions available to the industry to prevent these detrimental losses.
Coming up with solutions is of at most importance. Dalan's sustainable vaccine technology is uniquely positioned to have huge impact on the beekeeping industry and securing markets from food and feed supply to honey to pharma.
California’s massive almond industry, for example, relies almost entirely on honeybees for pollination.
Additional Global Bee Diseases:
